| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 01/05/2005 | CN1561199A Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 01/05/2005 | CN1560059A Synthesis process for Adefovir ester of anti hepatitis type B virus medicine |
| 01/05/2005 | CN1560058A Fluorine substituted phenoxy acetyl oxide alkyl phosphonate ester and salt with weeding active and preparation process thereof |
| 01/05/2005 | CN1560057A Preparationj process of high pureness phosphatidyl inositol |
| 01/05/2005 | CN1183148C Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium 2.5 hydrate or monohydrate |
| 01/05/2005 | CN1183147C Diphosphonic acid derivant and preparation process and application thereof |
| 01/05/2005 | CN1183146C Process for producing powdery phosphazene compound |
| 01/05/2005 | CN1183141C Vinyl-pyrrolidone cynnematin with alkali substituent |
| 01/05/2005 | CN1182917C Process to separate group 8-10 metal/phosphite ligand complex from organic liquid |
| 01/04/2005 | US6838474 Prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. This invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and |
| 01/04/2005 | US6838459 7-alkyl-and cycloalkyl-substituted imidazotriazinones |
| 01/04/2005 | US6838452 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 01/04/2005 | US6838198 Organic/inorganic-oxide multilayer materials |
| 01/04/2005 | US6837248 Reduced ignition propensity smoking article |
| 01/04/2005 | CA2158471C Process for the manufacture of aminomethanephosphonic acid |
| 12/30/2004 | US20040267040 Beta-ketophosphonates |
| 12/30/2004 | US20040267008 Cyclization of (2-Oxo-4-(2-oxo-2-(tetrahydrofuran-2-yl)-ethylsulfanyl)-3-phenylacetylamino -azetidin-1-yl)-(trimethyl- alpha -phosphanylidene)-acetic acid 4-nitro-benzyl ester; reacting with acid |
| 12/30/2004 | US20040266906 For bonding dental restoratives to dentin and/or enamel |
| 12/30/2004 | US20040266854 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 12/30/2004 | US20040266853 Small molecule antiproliferative agents |
| 12/30/2004 | US20040266748 Photosensitizing carbamate derivatives |
| 12/30/2004 | US20040266735 Bisphosphonate derivatives, their preparations and uses |
| 12/30/2004 | US20040266723 Antiviral agents for treatment of Flaviviridae infections |
| 12/30/2004 | US20040266720 Splice-region antisense composition and method |
| 12/30/2004 | US20040265958 that hydrolyzes fatty amides such as cis-9,10-octadecenoamide to neutralize the soporific activity of the fatty amides; enzyme inhibitors for use in treating sleep disorders |
| 12/30/2004 | US20040265927 Phospho-amino acid end groups interact with receptors on antigen-presenting cells; for treatment of T-cell mediated disorders (autoimmune conditions), inflammatory disorders, neurodegenerative disorders, and endothelial dysfunction disorders |
| 12/30/2004 | US20040265922 Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences |
| 12/30/2004 | US20040265885 Peptide nucleic acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone; can be purified using efficient methods such as chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents |
| 12/30/2004 | US20040265631 Rare earth metal complexed with phophine oxide containing ligand and a beta-diketone ligand; a fluoropolymer; excellent in solubility to a solvent and in resin dispersibility |
| 12/30/2004 | US20040265627 Organic electroluminescent devices, aminostyrylnaphthalene compound and synthesis intermediates thereof, and production processes of the same |
| 12/30/2004 | DE10327109A1 Novel intermediates and dichloro-biarylbisphosphines are useful as ligands for transition metal complex catalysts used in the production of enantiomer-enriched compounds |
| 12/29/2004 | WO2004113356A1 Crystalline carbapenem intermediate |
| 12/29/2004 | WO2004113355A1 Method for producing organic compounds containing poly-dopo, and the use of the same |
| 12/29/2004 | WO2004113277A2 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | WO2004113275A2 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | WO2004112704A2 Substituted piperidine compounds and methods of their use |
| 12/29/2004 | EP1492173A2 Light emitting device containing a rare earth complex as luminescent medium |
| 12/29/2004 | EP1490379A1 Bisphosphines as bidentate ligands |
| 12/29/2004 | EP1490173A2 Metalorganic catalysts for chemo-, regio- and stereoselective reactions, and corresponding precursors |
| 12/29/2004 | EP1490058A1 Peroxisome proliferator activated receptor modulators |
| 12/29/2004 | EP1490015A2 Novel 2-amino-9-((2-hydroxymethyl) cyclopropylidenemethyl) purines as antiviral agents |
| 12/29/2004 | EP1490014A2 Photosensitive adhesive composition |
| 12/29/2004 | EP1259521B1 Method for preparing bismuth tris-trifluoromethanesulphonate |
| 12/29/2004 | EP1119551B1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 12/29/2004 | CN1558910A Process for synthesis of organometallic compounds |
| 12/29/2004 | CN1558908A Novel diphosphines, their complexes with transisition metals and their use in asymmetric synthesis |
| 12/29/2004 | CN1557823A L- or D-amino acid-platinum ligand ,preparation method and use thereof |
| 12/29/2004 | CN1557820A Preparation for glyphosate from N-(phosphonomethyl)iminodiacetic acid (PMIDA) and its products ,and related process |
| 12/29/2004 | CN1182144C 1-substituted-alpha-phosphate ester-2-ethylenimine sulfenamide, preparation method and use |
| 12/29/2004 | CN1182143C Bis-(N,N'-bis-(2-haloethyl) amino) phosphoramidates as antitumor agents |
| 12/29/2004 | CN1181826C Lipid-based immune regulator composition |
| 12/29/2004 | CN1181825C Use of colchinol derivatives in preparation of vascular damaging agents drug |
| 12/29/2004 | CA2529524A1 Substituted piperidine compounds and methods of their use |
| 12/29/2004 | CA2529257A1 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | CA2529256A1 Methods and compositions for treating amyloid-related diseases |
| 12/28/2004 | US6835792 Solventless nontoxic high refractive index and low birefringence organic/inorganic hybrid materials |
| 12/28/2004 | US6835753 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 12/28/2004 | US6835721 Phosphate or ammonium compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases |
| 12/28/2004 | US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
| 12/28/2004 | US6835216 Chain-breaking antioxidants |
| 12/28/2004 | CA2236752C Phosphate esters of polyalkylene ether block copolymers and their use as dispersants |
| 12/23/2004 | WO2004111193A2 Prodrugs of mitotic kinesin inhibitors |
| 12/23/2004 | WO2004111158A1 Phosphite stabilizers and methods to preparation and polymer composition thereof |
| 12/23/2004 | WO2004111121A1 Reactive flame retardants and flame-retarded resin products |
| 12/23/2004 | WO2004111065A1 Ligands |
| 12/23/2004 | WO2004111064A1 Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs |
| 12/23/2004 | WO2004111063A2 Chiral ligands for application in asymmetric syntheses |
| 12/23/2004 | WO2004110979A2 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 12/23/2004 | WO2004031109A3 Chiral diols, their manufacture and ligands and catalysts derived therefrom |
| 12/23/2004 | WO2003087028A9 A method of making salt |
| 12/23/2004 | US20040260128 Solvent-free mechanochemical preparation of phosphonium salts, phosphorus ylides, and olefins |
| 12/23/2004 | US20040260118 Phosphonium salts and processes for production of and uses for the same, and phosphines deriving the same and processes for production of the phosphines |
| 12/23/2004 | US20040260101 With difluoromethylenedioxybenzene or ethylenedioxybenzene rings; hydrogenation catalysts |
| 12/23/2004 | US20040260091 Ligands for asymmetric reactions |
| 12/23/2004 | US20040260080 Solid phase synthesis; conjugation with lanthanide chelates via Mitsunobu alkylation |
| 12/23/2004 | US20040260041 catalysts for polymerizing olefins |
| 12/23/2004 | US20040259987 Flame retardant for polymeric materials |
| 12/23/2004 | US20040259986 Ammonium phosphite polymers with curing for fireproofing polymers |
| 12/23/2004 | US20040259846 Desolventizing by spray drying; bone disorders, osteoporosis; Paget's disease; osteoarthritis |
| 12/23/2004 | US20040259845 Herpes, hepatitis, and aids virus; administering phosphatides |
| 12/23/2004 | US20040259724 Carbonylation of pentenenitrile to 5-cyanovaleric acid; reduction to 6-aminocaporic acid; cyclization to caprolactam |
| 12/23/2004 | US20040258600 Crystallised IM-8 solid of metallophosphate type and process for the preparation thereof |
| 12/23/2004 | DE10325051A1 Ionische Flüssigkeiten mit Guanidinium-Kationen Ionic liquids with guanidinium cations |
| 12/23/2004 | DE10325050A1 Thiouronium or uronium salts with various anions, e.g. triflate or tetrakis-pentafluorophenyl-borate, used as ionic liquids, non-aqueous electrolytes, phase-transfer catalysts and surfactants |
| 12/23/2004 | DE10324891A1 Thiouronium or uronium salts with various anions, e.g. triflate or tetrakis-pentafluorophenyl-borate, used as ionic liquids, non-aqueous electrolytes, phase-transfer catalysts and surfactants |
| 12/23/2004 | CA2528238A1 Ligands |
| 12/23/2004 | CA2527977A1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 12/23/2004 | CA2527582A1 Prodrugs of mitotic kinesin inhibitors |
| 12/22/2004 | EP1489088A1 Novel alpha-amino-n-(diaminophosphinyl)lactam derivative |
| 12/22/2004 | EP1489087A1 Bisphosphine, process for producing the same, and use thereof |
| 12/22/2004 | EP1487851A2 A building block capable of functional entity transfer to nucleophil |
| 12/22/2004 | EP1487849A2 A building block capable of transferring a functional entity |
| 12/22/2004 | EP1487780A1 Haloacetamide and azide substituted compounds and methods of use thereof |
| 12/22/2004 | EP1487774A2 Bipolar trans carotenoid salts and their uses |
| 12/22/2004 | EP1487459A1 Peptide analogues and uses thereof |
| 12/22/2004 | EP1105063A4 Adhesive compositions for the hard tissues of the human body |
| 12/22/2004 | EP1086076B1 Sulfonamide inhibitors of aspartyl protease |
| 12/22/2004 | EP1025110B1 Weakly coordinating anions containing polyfluoroalkoxide ligands |
| 12/22/2004 | EP0987254B1 Novel cyclic diamine compounds and medicine containing the same |
| 12/22/2004 | CN1181083C Planar chiral [2,2]-p-cyclo-aralkyl oxazolinyl phosphine ligand and its synthesis and use |